AquaBounty Technologies (NASDAQ:AQB) Issues Quarterly Earnings Results

AquaBounty Technologies (NASDAQ:AQB) announced its earnings results on Tuesday. The company reported ($0.88) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.88), RTT News reports. AquaBounty Technologies had a negative net margin of 3,923.57% and a negative return on equity of 17.81%. The business had revenue of $0.05 million for the quarter, compared to analyst estimates of $0.10 million. During the same quarter last year, the business earned ($1.60) earnings per share.

AquaBounty Technologies Trading Down 2.6 %

NASDAQ:AQB traded down $0.03 on Wednesday, reaching $1.12. The company’s stock had a trading volume of 12,348 shares, compared to its average volume of 24,244. The company has a quick ratio of 1.96, a current ratio of 1.96 and a debt-to-equity ratio of 0.05. The firm has a market cap of $4.33 million, a price-to-earnings ratio of -0.06 and a beta of 1.15. The stock has a 50 day moving average price of $1.13 and a 200 day moving average price of $1.47. AquaBounty Technologies has a 12-month low of $0.81 and a 12-month high of $4.03.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.